Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 201-250 of 6028 result(s).
CYDY CytoDyn Inc
04/09/2025 12:49:27 PM
Do you think those statistics could (5)
CYDY CytoDyn Inc
04/09/2025 12:07:33 AM
given a patient population of 350.. (7)
CYDY CytoDyn Inc
04/08/2025 11:53:00 PM
Ohm, you posit..."Properly sized tr (15)
CYDY CytoDyn Inc
04/08/2025 2:20:52 AM
UNDERdosing seems to be a problem. (12)
CYDY CytoDyn Inc
04/08/2025 2:00:23 AM
The trial uses a PD-1 blocker calle (23)
CYDY CytoDyn Inc
04/07/2025 6:34:57 PM
Would this be compelling enough dat (3)
CYDY CytoDyn Inc
04/07/2025 6:30:13 PM
What reason would the FDA give - or (7)
CYDY CytoDyn Inc
04/07/2025 5:13:41 PM
Trodelvy vs. leronlimab in mTNBC Tr (21)
CYDY CytoDyn Inc
04/07/2025 2:55:08 PM
Thinking on what Bill Gated said ab (6)
CYDY CytoDyn Inc
04/07/2025 2:15:31 PM
I still don't know what to make of (3)
CYDY CytoDyn Inc
04/07/2025 1:54:21 PM
Why is Scott kelly All over these P (7)
CYDY CytoDyn Inc
04/07/2025 1:45:33 PM
Yes sir....& RECOVER is Congress ma (13)
CYDY CytoDyn Inc
04/07/2025 1:38:42 PM
Addition of a short HIV-1 fusion-in (5)
CYDY CytoDyn Inc
04/07/2025 1:35:52 PM
I find it interesting that Goose ca (1)
CYDY CytoDyn Inc
03/26/2025 1:18:48 AM
I've sorta resigned myself to never (9)
CYDY CytoDyn Inc
03/26/2025 1:01:39 AM
Casava Science gives up on their Al (14)
CYDY CytoDyn Inc
03/26/2025 12:53:40 AM
Our HIV cure is trying to use stem (11)
CYDY CytoDyn Inc
03/26/2025 12:07:55 AM
If the RECOVER-TLC team declines to (8)
CYDY CytoDyn Inc
03/24/2025 12:26:40 PM
Ohm, I'm very interested in the Alz (29)
CYDY CytoDyn Inc
03/24/2025 10:39:15 AM
From my vantage point which is that (7)
CYDY CytoDyn Inc
03/24/2025 10:26:17 AM
Has anyone done the research on if (19)
CYDY CytoDyn Inc
03/24/2025 10:20:42 AM
In again reviewing Dr Jay's shareho (27)
CYDY CytoDyn Inc
03/24/2025 10:11:17 AM
I think the board is thinking about (20)
CYDY CytoDyn Inc
03/24/2025 10:01:25 AM
WhoTF! is reindeer380...and Mr. For (4)
CYDY CytoDyn Inc
03/23/2025 1:57:48 AM
Dr. Carmichael on CCR5, CREB and GA (9)
CYDY CytoDyn Inc
03/23/2025 1:29:37 AM
February 21, 2019: “This is the f (9)
CYDY CytoDyn Inc
03/23/2025 12:49:01 AM
I am likely misremembering, but,... (8)
CYDY CytoDyn Inc
03/22/2025 12:24:22 PM
Got a crazy question, but what do y (22)
CYDY CytoDyn Inc
03/22/2025 7:22:10 AM
I did want to ask you your thoughts (11)
CYDY CytoDyn Inc
03/22/2025 2:23:29 AM
If it’s Goose back from the dead, (7)
CYDY CytoDyn Inc
03/22/2025 2:13:35 AM
Your posts are not passing the smel (18)
CYDY CytoDyn Inc
03/22/2025 2:03:33 AM
Nader was out way too far over his (6)
CYDY CytoDyn Inc
03/22/2025 1:47:12 AM
It would be nice to know if Patient (10)
CYDY CytoDyn Inc
03/22/2025 1:25:53 AM
I am a little confused about this.. (10)
CYDY CytoDyn Inc
03/22/2025 1:07:13 AM
Great idea, House, except that we h (9)
CYDY CytoDyn Inc
03/22/2025 1:02:52 AM
Maybe a silly question, but if we c (21)
CYDY CytoDyn Inc
03/22/2025 1:00:22 AM
I’ve been meaning to bring a ques (15)
CYDY CytoDyn Inc
03/22/2025 12:25:45 AM
I'm far from a MASH expert but ther (5)
CYDY CytoDyn Inc
03/22/2025 12:18:55 AM
Sure, some company might want to pa (7)
CYDY CytoDyn Inc
03/22/2025 12:13:55 AM
but the “not significant results (17)
CYDY CytoDyn Inc
03/22/2025 12:05:00 AM
Fat on the liver is the start of MA (21)
CYDY CytoDyn Inc
03/15/2025 1:13:35 AM
Ohm, do these indicate that CCR5 ca (17)
CYDY CytoDyn Inc
03/14/2025 11:48:31 PM
Is the start of a trial a PR moment (3)
CYDY CytoDyn Inc
03/13/2025 6:04:45 AM
Ohm please - your thoughts. Dr. Sac (12)
CYDY CytoDyn Inc
03/12/2025 12:19:33 PM
Has anyone heard of VAIDS ? Vaccine (6)
CYDY CytoDyn Inc
03/12/2025 10:32:26 AM
(14)
CYDY CytoDyn Inc
02/26/2025 11:57:32 PM
Now you can almost buy a dozen eggs (4)
CYDY CytoDyn Inc
02/26/2025 8:20:07 PM
Can the safety data from HIV BLA be (12)
CYDY CytoDyn Inc
02/26/2025 8:05:55 PM
I am I’m confident it’s intende (4)
CYDY CytoDyn Inc
02/26/2025 8:04:02 PM
(2)
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • Xcel Brands Prepares for Q2 Earnings Call and Future Growth
  • Shentel Celebrated with 2025 CableFax Top Ops Work Culture Award
  • Insight into Middlefield Canadian Income and Its Valuation
  • Hindustan Zinc's Membership Boosts Sustainable Mining Efforts
  • Revelio Labs Launches Public Labor Statistics for Transparency
  • Drucker + Falk Celebrates Allure at Edinburgh's Lease-Up Triumph
  • New Chief Operating Officer at Northwestern Mutual Appointed
  • California's Housing Affordability Experiences Minor Fluctuations
  • Uncovering Strategies to Combat Payment Fraud Effectively
  • Philanthropist Donates Life-Saving Devices to Community Safety
  • Treering's Growth Surge: Innovations in Memory Technology
  • Celebrating Excellence: Bloomberg Law's Top Young Lawyers of 2025
  • Expanding Opportunities in the Thriving Laser Optics Market
  • Crowley Unveils Torogoz: A New Era in Shipping Begins
  • Innovative Transfer Bed Enhances Mobility and Safety for Users
  • Haverhill Leach Inc. Celebrates Growth with 5000 Honor
  • Datalink Networks Partners with Clip Training for Digital Skill Enhancement
  • Exploring the Surge of MP Materials Amidst Global Demand
  • Vertiv's Earnings Reflect Growth Amid AI Infrastructure Needs
  • PayPoint plc Updates: PDMR Shareholdings and Awards Overview
  • Investor Alert: Legal Investigation into Alto Neuroscience Claims
  • Flywire Investors: Understanding Securities Class Action Moves
  • ODRAH Expands Services with State Farm® Insurance Partnership
  • Boost Your B2B Growth with MarketsandMarkets' New Hub
  • Aspo Prepares to Release Half-Year Financial Report Soon
  • The Growth Journey of Primerica: A 10-Year Investment Story
  • Hargreave Hale AIM VCT PLC Closes Subscription Offer
  • Affirm and Google Pay: A Strategic Leap in Online Payments
  • Kandi Technologies Expands Battery Swap Capabilities with New Deal
  • Drucker + Falk Celebrates Full Occupancy at Allure Apartments
  • Celebrating Diversity: Elevating Black Beauty in Our Culture
  • Investigation by Leading Firm for Centene Investors' Claims
  • Concerns Rise Over SelectQuote, Inc. Amid Class Action Lawsuit
  • Karin Sabey Takes the Helm as Care Resource's New CEO
  • Celebrate MAMMOTION's 9th Anniversary with Smart Lawn Discounts
  • Data Center Solutions Set to Surge to $1.1 Trillion by 2030
  • Altimmune's Growth: Key Highlights from Recent Earnings Call
  • Innovative Car Seat Design Revolutionizes Breastfeeding Comfort
  • Tactacam Ranks Among Fastest-Growing Private Firms in 2025
  • California Housing Affordability Trends: An Overview
  • Podobas Global Investments Takes Strategic Stake in Tripla Co.
  • YourMenu Achieves Major Milestone in Restaurant Technology
  • Marketing AI Institute's Remarkable Growth Recognized by Inc. 5000
  • Unlocking Revenue Growth with MarketsandMarkets' New Hub
  • Exploring the Rise of Organic Wine: A $30 Billion Opportunity
  • Exploring the Growth Potential of Veterinary Regenerative Medicine
  • Elemeno Health: A Beacon of Growth in Healthcare Innovation
  • Aspo's Financial Report Announcement and Conference Details
  • Innovative Methane Eradication System Revolutionizes Dairy Farming
  • Insights into Verkkokauppa.com Oyj's Shareholders' Nomination Board
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site